Mary Jo Williamson, chief administrative officer of Mayo Clinic Laboratories, shares four critical steps for successful healthcare collaborations.

In the second quarter of 2025, Mayo Clinic Laboratories expanded its test catalog with several innovative new tests.

The laboratory test catalog is no longer just a reference list — it’s a strategic asset. By expanding its content, laboratories can improve satisfaction and experience.

Elitza Theel, Ph.D., explains how Mayo Clinic Laboratories' unique Histoplasma/Blastomyces test provides cost-effective evaluation for fungal infections that cause pulmonary illness. The assay reliably detects both Histoplasma and Blastomyces pathogens in a single test.

This week's Research Roundup features: Elementary overview of heavy metals.

Faced with a population increase and the need to expand both laboratory testing capacity and capabilities, Yuma Regional Medical Center leaned into its relationship with Mayo Clinic Laboratories to gain insights to strengthen community ties, attract new providers, and positively impact patient outcomes.

Today's highlights include: End of Covid emergency will usher in changes across the US health system, vaccine makers prep bird flu shot for humans ‘just in case’; rich nations lock in supplies, and a nuclear power plant leaked contaminated water in Minnesota.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic, and Matthew Binnicker, Ph.D., director of the Clinical Virology Laboratory at Mayo Clinic, discuss why avian influenza has recently been in the news and lessons learned from managing COVID-19.

Since March 2020, the COVID-19 pandemic has had a lasting impact on the lives of millions of people around the world, including the many brave health care workers who risked their own health to provide lifesaving care to those infected by the virus. That care was made possible, in part, by the lasting impact that the pandemic has also had on laboratory testing.

Mayo Clinic Laboratories has developed a new direct ethanol biomarker test for alcohol consumption that has a much longer detection window than existing urine tests for alcohol use.

This week's Research Roundup features: Performance comparisons of methylation and structural variants from low-input whole-genome methylation sequencing.

Zhiyv (Neal) Niu, Ph.D., and Rodolfo Savica, M.D., Ph.D., explain why Mayo Clinic Laboratories' gene panel is the most comprehensive test available for inherited Parkinson's disease. The new panel covers all mutations known to cause the condition — or increase the risk of developing it.

On this episode of Mayo Clinic Laboratories’ “Leveraging the Laboratory” podcast, host Jane Hermansen, outreach manager, returns with outreach solutions strategists Ellen Dijkman Dulkes and Brianne Newton to chat about National Medical Laboratory Professionals Week, April 23–29.

Today's Highlights Include: Rochester public schools receives grant to support youth mental health, and FDA releases new regs intended to help detect breast cancer sooner.

In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., speaks with Robert Michel, editor-in-chief of The Dark Report, an intelligence service and publication that provides economic and strategic assessment of the clinical laboratory industry, to provide useful tools for laboratory management.